Informationen:
Fehler:
ID
25951
Beschreibung
Investigators Statement Ropinirole Case Report Form GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Stichworte
Versionen (1)
- 01.10.17 01.10.17 -
Rechteinhaber
gsk
Hochgeladen am
1. Oktober 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Ähnliche Modelle
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
INVESTIGATOR’S STATEMENT
C1710187 (UMLS CUI-1)
C2826892 (UMLS CUI-2)
C2826892 (UMLS CUI-2)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
completion
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C0805732 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
consent
Item
I certify to the best of my knowledge, that the observations and findings are recorded correctly and completely in this CRF.
boolean
C1511481 (UMLS CUI [1])
Investigator
Item
Investigator
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])
Keine Kommentare